EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating Splice Defects in USH2A Using Targeted Long-Read Sequencing

Shwetha Chandrasekhar, Siying Lin iD, Neringa Jurkute, Kathryn Oprych, Leire Estramiana Elorrieta iD, Elena Schiff iD, Samantha Malka iD, Genevieve Wright, Michel Michaelides, Omar A Mahroo iD, Andrew R Webster, Gavin Arno

Cells · 2024

DOI: 10.3390/cells13151261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Shwetha Chandrasekhar und 11 weiteren Autor:innen. Beteiligte Einrichtung: UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK. Hauptthemen laut MEDLINE: Extracellular Matrix Proteins, Usher Syndromes, RNA Splicing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Fight for Sight UK, Moorfields Eye Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biallelic variants in USH2A are associated with retinitis pigmentosa (RP) and Type 2 Usher Syndrome (USH2), leading to impaired vision and, additionally, hearing loss in the latter. Although the introduction of next-generation sequencing into clinical diagnostics has led to a significant uplift in molecular diagnostic rates, many patients remain molecularly unsolved. It is thought that non-coding variants or variants of uncertain significance contribute significantly to this diagnostic gap. This study aims to demonstrate the clinical utility of the reverse transcription–polymerase chain reaction (RT-PCR)–Oxford Nanopore Technology (ONT) sequencing of USH2A mRNA transcripts from nasal epithelial cells to determine the splice-altering effect of candidate variants. Five affected individuals with USH2 or non-syndromic RP who had undergone whole genome sequencing were recruited for further investigation. All individuals had uncertain genotypes in USH2A, including deep intronic rare variants, c.8682-654C>G, c.9055+389G>A, and c.9959-2971C>T; a synonymous variant of uncertain significance, c.2139C>T; p.(Gly713=); and a predicted loss of function duplication spanning an intron/exon boundary, c.3812-3_3837dup p.(Met1280Ter). In silico assessment using SpliceAI provided splice-altering predictions for all candidate variants which were investigated using ONT sequencing. All predictions were found to be accurate; however, in the case of c.3812-3_3837dup, the outcome was a complex cryptic splicing pattern with predominant in-frame exon 18 skipping and a low level of exon 18 inclusion leading to the predicted stop gain. This study detected and functionally characterised simple and complex mis-splicing patterns in USH2A arising from previously unknown deep intronic variants and previously reported variants of uncertain significance, confirming the pathogenicity of the variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular Matrix ProteinsUsher SyndromesRNA SplicingHumansFemaleMaleHigh-Throughput Nucleotide SequencingExonsMutationRetinitis PigmentosaAdultRNA, MessengerIntronsMiddle Aged

Stichwörter der Autor:innen

Oxford nanopore sequencingUSH2Acryptic splice-altering variantdeep intronic variantinherited retinal diseaselong-read sequencingnasal epithelial cells

Substanzen

USH2A protein, humanExtracellular Matrix ProteinsRNA, Messenger

Autor:innen und Institutionen

  • UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
  • National Institute of Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, London EC1V 9EL, UK.
  • Department of Neuro-Ophthalmology, The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.
  • Clinical Genetics, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, UK.
  • Section for Paediatrics, Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London W2 1NY, UK.
  • Department of Ophthalmology, St Thomas' Hospital, London SE1 7EH, UK.

ORCID-Profile: Siying Lin, Leire Estramiana Elorrieta, Elena Schiff, Samantha Malka, Omar A Mahroo

Förderung

  • Wellcome Trust
  • Fight for Sight UK
  • Moorfields Eye Charity
  • National Institute of Health Research Biomedical Research Centre (NIHR-BRC) at Moorfields Eye Hospital and UCL Institute of Ophthalmology
  • NIGMS NIH HHS
  • Fight For Sight UK Early Career Investigator Award
  • National Institute of Health Research Biomedical Research Centre (NIHR-BRC) at Moorfields Eye Hospital
  • UCL Institute of Ophthalmology, NIHR-BRC at the Great Ormond Street Hospital Institute for Child Health and Moorfields Eye Charity

Zitieren

APA

Chandrasekhar, S., Lin, S., Jurkute, N., Oprych, K., Estramiana Elorrieta, L., Schiff, E., Malka, S., Wright, G., Michaelides, M., Mahroo, O. A., Webster, A. R., & Arno, G. (2024). Investigating Splice Defects in USH2A Using Targeted Long-Read Sequencing. Cells. https://doi.org/10.3390/cells13151261

Vancouver

Chandrasekhar S, Lin S, Jurkute N, Oprych K, Estramiana Elorrieta L, Schiff E, et al. Investigating Splice Defects in USH2A Using Targeted Long-Read Sequencing. Cells. 2024. doi:10.3390/cells13151261

BibTeX
@article{Chandrasekhar2024,
  author = {Chandrasekhar, Shwetha and Lin, Siying and Jurkute, Neringa and Oprych, Kathryn and Estramiana Elorrieta, Leire and Schiff, Elena and Malka, Samantha and Wright, Genevieve and Michaelides, Michel and Mahroo, Omar A and Webster, Andrew R and Arno, Gavin},
  title = {Investigating Splice Defects in USH2A Using Targeted Long-Read Sequencing},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13151261}
}
Kostenlos starten →